This content is machine translated Case report: Drug-induced hepatitis Rare side effect of tirzepatide therapy The dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide 1 (GLP1) receptor agonist triazepatide has shown promise for improving glycemic control and weight loss. However, it can also have undesirable side effects....…
